Clinical Trial Update: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a recombinant anti-tumor and anti-virus protein for injection in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Recombinant anti-tumor and anti-virus protein for injection

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED